Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Precision Therapeutics Inc (NQ: AIPT )

0.6400 USD UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 13, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Precision Therapeutics Inc

< Previous 1 2 Next >
Predictive Oncology Inc. (Formerly Precision Therapeutics) Names Amelia Warner, Pharm.D., RPh, as Interim Chief Operating Officer of Helomics
Predictive Oncology Inc. (Nasdaq: AIPT) (“Predictive Oncology” or the “Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today it... 
From GlobeNewswire News Releases
Precision Therapeutics Announces Corporate Name Change To Predictive Oncology Inc.
Nasdaq ticker expected to change to POAI Effective Thursday, June 13, 2019 
From GlobeNewswire News Releases
Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant
Precision Therapeutics Inc., (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that its... 
From GlobeNewswire News Releases
Precision Therapeutics Gains Extension for Nasdaq Compliance
Precision Therapeutics Inc. (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that Nasdaq... 
From GlobeNewswire News Releases
Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
Management to Host Conference Call to Review Financial Results and Provide Corporate Update at 4:30PM Today 
From GlobeNewswire News Releases
Precision Therapeutics to Report First Quarter 2019 Financial Results and Provide Company Update on Wednesday, May 15, 2019
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces that it will report First Quarter 2019 financial results for the period ended March 31, 2019, after the market... 
From GlobeNewswire News Releases
Precision Therapeutics’ Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a services agreement between its wholly owned subsidiary, Helomics and the National Alopecia Areata Foundation... 
From GlobeNewswire News Releases
Precision Therapeutics’ Subsidiary TumorGenesis and its Partner 48Hour Discovery Inc. Receive Alberta Innovates Product Demonstration Program Grant to Support Development of Novel Cancer Treatments
Collaboration Receives $300,000 CAD Grant to Further Develop and Commercialize TumorGenesis Oncology Discovery Technologies 
From GlobeNewswire News Releases
Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients
Helomics to provide CRO services and its D-CHIP artificial intelligence (AI) platform to SpeciCare for their PIONEER Initiative functional precision medicine trial 
From GlobeNewswire News Releases
Precision Therapeutics’ Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a collaboration between its wholly owned subsidiary, Helomics, and Viome, a new kind of healthcare company... 
From GlobeNewswire News Releases
Precision Therapeutics Announces Completion of Merger with Helomics Holding Corporation
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision Therapeutics” or “the Company”), today announced the completion of its merger with Helomics Holding Corporation (“Helomics”), which has become the... 
From GlobeNewswire News Releases
Precision Therapeutics Reports Year End 2018 Financial Results and Provides Corporate Update
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to Women’s Oncology, announced today financial results for the quarter... 
From GlobeNewswire News Releases
Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.
Dawson James Securities Inc. in conjunction with Precision Therapeutics Inc. (NASDAQ: AIPT) announced the closing on March 28th of its public offering of 1,478,750 units at $.80 per unit. Each unit... 
From GlobeNewswire News Releases
Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.2 Million of Units
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced the pricing of its previously announced public offering of its common stock and warrants to purchase common... 
From GlobeNewswire News Releases
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a proposed public offering of its common stock and warrants to purchase common stock. The offering is subject... 
From GlobeNewswire News Releases
Precision Therapeutics Announces Results of Special Meeting of Stockholders
Precision Therapeutics Inc. (Nasdaq: AIPT) (the “Company”) announced today that at a special meeting of stockholders held on March 22, 2019, the Company’s stockholders approved the Amended and Restated... 
From GlobeNewswire News Releases
Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019
Conference Call to be held April 1, 2019, at 4:30pm Eastern Time 
From GlobeNewswire News Releases
Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients
Viome, a company transforming health through personalized nutrition based on individual biology, today announces it will collaborate with precision health leader, Helomics, to study the link between... 
From PR Newswire
Precision Therapeutics Extends Exchange Offer for Helomics Notes and Warrants
Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”) today announced the extension of its previously announced offer (the “Exchange Offer”) to holders of certain promissory notes (the... 
From GlobeNewswire News Releases
Precision Therapeutics’ Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increase
Company Concluded 2018 With 38 Percent Increase in STREAMWAY System Disposables 
From GlobeNewswire News Releases
Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.
Dawson James Securities Inc. in conjunction with Precision Therapeutics Inc. (NASDAQ: AIPT) announced today the closing of its public offering of 1,385,000 Units with each unit consisting of one share... 
From GlobeNewswire News Releases
Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of Units
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced the pricing of its previously announced public offering of its common stock and warrants to purchase common... 
From GlobeNewswire News Releases
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a proposed public offering of its common stock and warrants to purchase common stock. The offering is subject... 
From GlobeNewswire News Releases
Precision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange Offer
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision”) today announced the effectiveness of its Form S-4 registration statement, the establishment of the date of its special meeting of stockholders... 
From GlobeNewswire News Releases
Precision Therapeutics’ Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY® System for automated,... 
From GlobeNewswire News Releases
Precision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces its TumorGenesis subsidiary has identified three thyroid cancer cell types and has isolated the discovery... 
From GlobeNewswire News Releases
Precision Therapeutics’ Skyline Medical Division Widens Global Reach Through New Taiwanese Distribution Agreement with Winner Scientific
Company Further Expands Global Outreach Through Exhibition at Arab Health Show in Dubai 
From GlobeNewswire News Releases
Precision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO Magazine
From ACCESSWIRE
Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz
Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its chief executive officer and director, Carl Schwartz, has made an additional investment of $1,000,000... 
From GlobeNewswire News Releases
Precision Therapeutics’ Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center
Large Sale to Prestigious Health System Further Validates STREAMLINE Utility 
From GlobeNewswire News Releases
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.